TrialThe Journal of clinical investigation2015

Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects.

John S Millar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.